Investor Alert

April 8, 2020, 2:22 a.m. EDT

Anticoagulants Market by Top Key Players are Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., Eisai Co., Ltd.

The Anticoagulants Market report provides an in-depth analysis of the market and focuses on aspects such as growth drivers, restraints, leading products, and major industry developments. It discusses the competitive landscape of the market and labels out leading players.

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Apr 08, 2020 (The Expresswire) -- The global “ anticoagulants market size ” is projected to reach 45.50 billion by the end of 2026. According to a report published by Fortune Business Insights, titled “Anticoagulants Market Size, Share and Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” the market was worth USD 21.45 billion in 2018 and will exhibit a CAGR of 9.9% during the forecast period,2019-2026.

Leading Players operating in the Anticoagulants Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Bristol-Myers Squibb Company

  • Pfizer Inc.

  • Bayer AG

  • Janssen Pharmaceuticals, Inc.

  • Eisai Co., Ltd

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anticoagulants-market-101807

Increasing Number of Company Mergers Will Aid Market Growth

Several growth stimulating factors have been analyzed and discussed in detail. Among all factors, the increasing number of company mergers have had the highest impact on the market. In February 2019, Novartis AG and Blackstone’s LifeSciences announced the launch of Anthos Therapeutics. The company is aiming for the research and development of drugs that include anticoagulants as a prime pipeline candidate. Increasing number of drug approvals is another factor that has constituted an increase in the global anticoagulants market size in recent years. Janssen Pharmaceuticals’ Rivaroxaban is an example of a recent drug approval that has had a direct impact on the market.

Detailed Table of Content:

  1. Introduction

  2. Executive Summary

  3. Market Dynamics

  4. Key Insights

  5. Global Anticoagulants Market Analysis, Insights and Forecast, 2015-2026

TOC Continued….

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anticoagulants-market-101807

Market Segmentation:

By Disease Indication

  • Pulmonary Embolism (PE)

  • Deep Vein Thrombosis (DVT)

  • Atrial Fibrillation

  • Heart Attacks

  • Others

By Route of Administration

  • Oral

  • Injectable

By Distribution Channel

  • Hospitals Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.